Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386704664> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4386704664 abstract "There are no recommended biomarkers to identify patients with refractory metastatic colorectal cancer (mCRC) who would benefit the most from trifluridine/tipiracil (TTP). The exploratory analysis of the RECOURSE trial revealed that patients with low tumor burden and indolent disease derive greater benefit in terms of both progression-free (PFS) and overall survival (OS). Nevertheless, the final answer on the TTP real impact on the well-being of patients with late-stage mCRC will come from real-world data.The aim of this retrospective exploratory study was to investigate the effectiveness of TTP in mCRC with regard to the duration of standard treatment and other influencing variables. The study included 260 patients from the three largest Croatian oncology centers who began treatment with TTP in the third or fourth line between 2018 and 2020.The median OS and PFS for the entire cohort were 6.53 and 2.50 months, respectively. Patients with more aggressive disease, defined as those whose time to progression on the first two lines of standard therapy was less than 18 months, had significantly shorter PFS (2.40 vs. 2.57 months, HR 1.34 95%CI 1.03-1.84). There was also a tendency towards shorter OS (6.10 vs. 6.30 months, HR 1.32, 95%CI 0.99-1.78) but without statistical significance. Patients with ECOG PS 0, without liver metastases, and with RAS mutation had both longer OS and PFS. No influence was detected from other variables including age, sex, primary tumor location, and tumor burden.With regard to the results of the previously conducted trials, the study concludes that indolent disease, good general condition, and absence of liver metastases are positive predictive factors for TTP treatment." @default.
- W4386704664 created "2023-09-14" @default.
- W4386704664 creator A5006102591 @default.
- W4386704664 creator A5018098152 @default.
- W4386704664 creator A5030713843 @default.
- W4386704664 creator A5051612903 @default.
- W4386704664 creator A5073854232 @default.
- W4386704664 creator A5088648639 @default.
- W4386704664 date "2023-09-12" @default.
- W4386704664 modified "2023-10-14" @default.
- W4386704664 title "Predicting Trifluridine/Tipiracil Treatment Outcomes in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis" @default.
- W4386704664 doi "https://doi.org/10.1159/000533567" @default.
- W4386704664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37699377" @default.
- W4386704664 hasPublicationYear "2023" @default.
- W4386704664 type Work @default.
- W4386704664 citedByCount "0" @default.
- W4386704664 crossrefType "journal-article" @default.
- W4386704664 hasAuthorship W4386704664A5006102591 @default.
- W4386704664 hasAuthorship W4386704664A5018098152 @default.
- W4386704664 hasAuthorship W4386704664A5030713843 @default.
- W4386704664 hasAuthorship W4386704664A5051612903 @default.
- W4386704664 hasAuthorship W4386704664A5073854232 @default.
- W4386704664 hasAuthorship W4386704664A5088648639 @default.
- W4386704664 hasConcept C121332964 @default.
- W4386704664 hasConcept C121608353 @default.
- W4386704664 hasConcept C126322002 @default.
- W4386704664 hasConcept C142424586 @default.
- W4386704664 hasConcept C143998085 @default.
- W4386704664 hasConcept C2776694085 @default.
- W4386704664 hasConcept C2780739268 @default.
- W4386704664 hasConcept C526805850 @default.
- W4386704664 hasConcept C71924100 @default.
- W4386704664 hasConcept C72563966 @default.
- W4386704664 hasConcept C87355193 @default.
- W4386704664 hasConceptScore W4386704664C121332964 @default.
- W4386704664 hasConceptScore W4386704664C121608353 @default.
- W4386704664 hasConceptScore W4386704664C126322002 @default.
- W4386704664 hasConceptScore W4386704664C142424586 @default.
- W4386704664 hasConceptScore W4386704664C143998085 @default.
- W4386704664 hasConceptScore W4386704664C2776694085 @default.
- W4386704664 hasConceptScore W4386704664C2780739268 @default.
- W4386704664 hasConceptScore W4386704664C526805850 @default.
- W4386704664 hasConceptScore W4386704664C71924100 @default.
- W4386704664 hasConceptScore W4386704664C72563966 @default.
- W4386704664 hasConceptScore W4386704664C87355193 @default.
- W4386704664 hasLocation W43867046641 @default.
- W4386704664 hasLocation W43867046642 @default.
- W4386704664 hasOpenAccess W4386704664 @default.
- W4386704664 hasPrimaryLocation W43867046641 @default.
- W4386704664 hasRelatedWork W2139647583 @default.
- W4386704664 hasRelatedWork W2465617904 @default.
- W4386704664 hasRelatedWork W2540335153 @default.
- W4386704664 hasRelatedWork W2598512998 @default.
- W4386704664 hasRelatedWork W3179015302 @default.
- W4386704664 hasRelatedWork W4237412880 @default.
- W4386704664 hasRelatedWork W4292087709 @default.
- W4386704664 hasRelatedWork W4327920375 @default.
- W4386704664 hasRelatedWork W4380150309 @default.
- W4386704664 hasRelatedWork W4385856392 @default.
- W4386704664 isParatext "false" @default.
- W4386704664 isRetracted "false" @default.
- W4386704664 workType "article" @default.